Caution, this is an AI generated summary based on literature. This may have errors, see here for more.
Please share your feedback with us.
hsa-mir-3665: Hsa-mir-3665 is a miRNA that has been mentioned multiple times in the provided text. It is one of the most representative miRNAs, along with hsa-let-7c-5p, hsa-miR-181a-5p, and hsa-miR-7704 [PMC9818028]. It has been found to be up-regulated in team A [PMC4222264], team B [PMC4222264], and VP [PMC4865051]. Additionally, hsa-mir-3665 is one of the top 10 PLK1 mRNA-targeting miRNAs [PMC9811677]. The differential abundance of hsa-mir-3665 has been validated in Parkinson's disease patients compared to healthy controls [PMC8065836]. It has also been reported as a seldom mentioned miRNA [PMC6571392]. Hsa-mir-3665 was used in transient transfection experiments with SiHa and CaSki cells [PMC5190061], and its methylation was found to be absent in most samples but increased in SCCs [PMC5190061]. Furthermore, it was down-regulated by 5-10-fold along with other miRNAs (hsa-miR-199a-2, hsa-miR410, hsa-miR487-b) within a miRNA family [PMC4320460]. Hsa-mir-3665 was also found to exhibit regulation during wound healing experiments using HDFa cells [PMC8876102], and its expression was comparatively high along with other miRNAs (hsa-miR3960, hsa-miR1469) within a cluster of miRNAs. Finally, it has been assigned the name "hsa-mir3665" in the miRBase database[ PMC2886071].
Genome locations
Gene Ontology annotations
Ancestor Chart
Loading ontology ancestors...
Failed to load QuickGO Ancestor chart
Sequence
Sequence features are shown above as colored rectangles.
Zoom in and click to view details, or
Reset